Reducing Taxes and Regulations Trumps Price Controls
Is Trump focusing on the wrong thing?
Addiction Risks Rise after Day Three of an Opioid Prescription
The length of an initial opioid prescription influences the risks of long-term use.
Fighting Opioid Abuse
How pharmacists can help fight the battle.
FDA Approves Rucaparib for Advanced Ovarian Cancer
The New Drug Review for April
Drug Spending Slows for Major Pharmacy Benefit Managers
Anakinra for RA and Refractory Idiopathic Recurrent Pericarditis
Cardiac Matters-What you need to know about anakinra
How Pill Bottles Can Deter Opioid Misuse and Abuse
Special pill bottle caps can help reduce medication misuse and abuse.
Alternatives to Opioids
How Trinity Health and Pacira are minimizing opioid use.
How Drug Companies use Loopholes to Delay Generic Drug Approvals
The citizens petition process is being used to delay approval of generic drugs.
Inside the $100 Million Opioids Ring
How physicians made millions and fed the opioid epidemic.
New Mexico Takes Big Step Against Opioid Epidemic
New legislation could be a model for other states.
What Home DNA Tests Really Tell Us
23andMe recently gained FDA approval, but will it actually help keep people healthier?
Fred's Could Help Rite Aid/Walgreens Deal Go Through
The chain has said it remains committed to buying Rite Aid stores.
An Opioid Story Earns a Pulitzer
A reporter earned the biggest journalism prize covering the opioid crisis.
Pharmacists Are Central to Supervalu Diabetes Campaign
Supervalu’s diabetes campaign offers risk assessments, screening, and food education.
Study: New Diabetes Drug Class Reduces Heart Deaths
New class of glucose-lowering agents lowers hospitalization and death rates even in Type 2 patients without heart disease.
The Trump Administration Gets Tough on Opioids
Trump and Gottlieb are both taking steps to end the opioid epidemic. But is it enough?
Small Doses: Pharmacy News Featuring Opioids, Ketamine, and More
Small Doses is news for pharmacists in a way that works for you.
Walgreens and Prime Therapeutics Create Specialty Pharma Mail Firm
What the new company will mean for specialty pharmacy.
MS Group Praises New Drug Despite High Price Tag
Why a drug that costs $65,000 a year is making patient groups happy.
GSK Issues Voluntary Recall
Nearly 600,000 inhalers are being recalled.
EpiPen and EpiPen Jr. Recalled: Recall Expanded from Europe and Asia
Two previous reports of device failures lead EpiPen maker to expand recall to the United States.
The Full Extent of Antibiotic Use in the United States? No One Knows.
What we know-and what we don't-about antibiotics in America.
The Health Economics of Medical Pot and the Pharmacist’s Role
Even medical marijuana has health-care costs and outcomes.
WHO Launches Program to Reduce Medication Errors
How a program hopes to cut errors in half.
As More Canadian Provinces Mandate Error Reporting, U.S. Experts Call for Similar Laws
Ontario joins Nova Scotia in making medication dispensing error reporting mandatory, but no states have enacted similar laws.
What to do About Rising Health-Care Costs?
Taking a clear-eyed look at the cost of health care can reduce waste.
What’s in the Specialty Pharmacy Pipeline?
Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017.
New York City Program Aims to Slash Opioid Deaths
What New York City is doing to curb the opioid epidemic.
Roundup of the APhA 2017 Annual Meeting and Exposition
This year's meeting highlighted the opioid epidemic and ways pharmacists can improve patient care.
